Laboratorios Farma | ROVI - PE价格收益

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.01B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	Pe	更改		日
Akebia Therapeutics	1.63K		1.6K	2025-12
Almirall	79.43		0.3	2025-12
Dianthus Therapeutics	3.8		1.53	2024-09
Ionis Pharmaceuticals	396.15		79.28	2022-09
IQVIA Holdings	19.37		7.21	2026-03
Laboratorios Farma	18.78		6.64	2023-12
Moderna	27.22		14.51	2023-06
Organon & Co	3.75		0.87	2025-12
Pharma Mar	19.13		1.72	2026-03
Revvity	30.79		19.08	2026-03
Tectonic Therapeutic	4.01		0.63	2024-03
Viatris	14.61		4.21	2026-03